Sonosemi Medical Co., Ltd.
PrivateLast Round
Series B
Extension
Jul 8, 2026
Total Funding Raised
$41.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sonosemi Medical Co., Ltd. operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Series B Extension round in July 2026.
Sonosemi Medical Co., Ltd. is a medical device company that specializes in the research, development, and commercialization of pan-vascular active interventional diagnosis and treatment solutions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sonosemi Medical Co., Ltd. Comparables
Compare Sonosemi Medical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genesis MedTech Group | 85% | |
| 上海汇禾医疗科技股份有限公司 | 83% | |
| Shenzhen Xinhuan Technology Co., Ltd. | 81% |
For institutional investors. Book with your work email.
Sonosemi Medical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jul 8, 2026 | ||||
| Series B | Oct 26, 2023 | ||||
| Series A | Apr 12, 2022 | ||||
| Pre Seed | Jun 28, 2021 | ||||
| Angel | Nov 1, 2020 |
For institutional investors. Book with your work email.
Sonosemi Medical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Alwin Capital | Series A, Series B, Series B Extension |
| Tencent Exploration | Series A, Series B |
| Eight Roads Ventures | Pre Seed, Series A, Series B Extension |
| Furong Investment | Series A, Series B Extension |
| CoStone Capital | Series B |
| Guangzhou Yuexiu Industrial Investment Fund Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 8, 2026
Led by Alwin Capital and Eight Roads Ventures.
- Oct 26, 2023
$27.2M round led by Guangzhou Yuexiu Industrial Investment Fund Management.
For institutional investors. Book with your work email.
Sonosemi Medical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sonosemi Medical Co., Ltd.'s valuation, stock price, and market status.
Is Sonosemi Medical Co., Ltd. a public or private company?
Sonosemi Medical Co., Ltd. is a private company.
What is the current stock price of Sonosemi Medical Co., Ltd.?
Sonosemi Medical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Sonosemi Medical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sonosemi Medical Co., Ltd. worth (valuation)?
Valuation information for Sonosemi Medical Co., Ltd. is not publicly available.
Can I buy Sonosemi Medical Co., Ltd. stock?
Sonosemi Medical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sonosemi Medical Co., Ltd.'s last funding round?
Sonosemi Medical Co., Ltd.'s most recent funding round was Series B Extension on July 8, 2026.
Who are the main investors in Sonosemi Medical Co., Ltd.?
Key investors in Sonosemi Medical Co., Ltd. include Alwin Capital, Eight Roads Ventures, Guangzhou Yuexiu Industrial Investment Fund Management.
Will Sonosemi Medical Co., Ltd. IPO soon?
No public IPO plans have been announced for Sonosemi Medical Co., Ltd..
How can I track Sonosemi Medical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Sonosemi Medical Co., Ltd.'s shares on secondary markets.